Bolliger, M., Wasinger, D., Brunmair, J., Hagn, G., Wolf, M., Preindl, K., Reiter, B., Bileck, A., Gerner, C., Fitzal, F., & Meier-Menches, S. M. (2025). Mass spectrometry-based analysis of eccrine sweat supports predictive, preventive and personalised medicine in a cohort of breast cancer patients in Austria. The EPMA journal. Advance online publication. https://doi.org/10.1007/s13167-025-00396-6

Paulitschke, V., Zila, N., Bileck, A., Stary, G., Borik-Heil, L., Dadak, L., Wolf, M., Wasinger, D., Aguilar-Gonzales, A., Harikumar, N., Kunstfeld, R., Weninger, W., Hoeller, C., & Gerner, C. (2024). Proteomic and Metabolomic Profiling of Female Patients with advanced Melanoma to Predict and Monitor Response to anti-PD1 Immunotherapy. Journal der Deutschen Dermatologischen Gesellschaft, 22(Suppl. 4), 33-34. Article Meeting Abstract FV46.

Pristner, M., Wasinger, D., Seki, D., Klebermaß-Schrehof, K., Berger, A., Berry, D., Wisgrill, L., & Warth, B. (2024). Neuroactive metabolites and bile acids are altered in extremely premature infants with brain injury. Cell Reports Medicine, 5(4), Article 101480. https://doi.org/10.1016/j.xcrm.2024.101480

Jamnik, T., Flasch, M., Braun, D., Fareed, Y., Wasinger, D., Seki, D., Berry, D., Berger, A., Wisgrill, L., & Warth, B. (2022). Next-generation biomonitoring of the early-life chemical exposome in neonatal and infant development. Nature Communications, 13(1), Article 2653. https://doi.org/10.1038/s41467-022-30204-y